CD8A and glioma: A recent study using the engineered GL26 glioma cell line expressing ovalbumin demonstrated successful confocal microscopic imaging of tumor antigen-specific CD8+ T cells localized within the tumor area following immunotherapeutic treatment, which corresponded to reductions in tumor burden and mortality[8].